Ventyx prices upsized $151.5 million IPO
LONDON, UK: RTW Venture Fund Limited’s portfolio company Ventyx Biosciences Inc. announced pricing of an upsized $151.5 million initial public offering (IPO) and admission to trade on Nasdaq Global Market under ticker “VTYX”. Ventyx is a clinical-stage biopharmaceutical company advancing…